C
Christopher Gerner
Researcher at University of Vienna
Publications - 232
Citations - 7198
Christopher Gerner is an academic researcher from University of Vienna. The author has contributed to research in topics: Proteome & Proteomics. The author has an hindex of 41, co-authored 204 publications receiving 5890 citations. Previous affiliations of Christopher Gerner include Medical University of Vienna & Institute of Cancer Research.
Papers
More filters
Journal ArticleDOI
RNase P without RNA: Identification and Functional Reconstitution of the Human Mitochondrial tRNA Processing Enzyme
Johann Holzmann,Peter Frank,Esther Löffler,Keiryn L. Bennett,Christopher Gerner,Walter Rossmanith +5 more
TL;DR: It is demonstrated that human mitochondrial RNase P is a protein enzyme that does not require a trans-acting RNA component for catalysis, and the mitochondrial enzyme turns out to be an unexpected type of patchwork enzyme, composed of a tRNA methyltransferase, a short-chain dehydrogenase/reductase-family member, and a protein of hitherto unknown functional and evolutionary origin.
Journal ArticleDOI
Executioner caspase-3 and caspase-7 are functionally distinct proteases
John G. Walsh,Sean P. Cullen,Clare Sheridan,Alexander U. Lüthi,Christopher Gerner,Seamus J. Martin +5 more
TL;DR: The observations provide a molecular basis for the different phenotypes seen in mice lacking either caspase and indicate that these proteases occupy nonredundant roles within the cell death machinery.
Journal ArticleDOI
Structure–activity relationships for ruthenium and osmium anticancer agents – towards clinical development
Samuel M. Meier-Menches,Samuel M. Meier-Menches,Christopher Gerner,Walter Berger,Walter Berger,Christian G. Hartinger,Bernhard K. Keppler +6 more
TL;DR: Global structure-activity relationships are discussed for ruthenium and osmium metallodrugs with respect to in vitro antiproliferative/cytotoxic activity and in vivo tumor-inhibiting properties, as well as pharmacokinetics.
Journal ArticleDOI
Serum Amyloid A in Uremic HDL Promotes Inflammation
Thomas Weichhart,Chantal Kopecky,Markus Kubicek,Michael Haidinger,Dominik Döller,Karl Katholnig,Cacang Suarna,Philipp Eller,Markus Tölle,Christopher Gerner,Gerhard J. Zlabinger,Markus van der Giet,Walter H. Hörl,Roland Stocker,Marcus D. Säemann +14 more
TL;DR: It is observed that HDL isolated from healthy individuals inhibited the production of inflammatory cytokines by peripheral monocytes stimulated with a Toll-like receptor 2 agonist, suggesting a potential link between the high levels of inflammation and cardiovascular mortality in uremia.
Journal ArticleDOI
The Fas-induced apoptosis analyzed by high throughput proteome analysis.
Christopher Gerner,Ulrike Fröhwein,Josef Gotzmann,Editha Bayer,Dieter Gelbmann,Wilfried Bursch,Rolf Schulte-Hermann +6 more
TL;DR: F Fas-induced proteome alterations were compared with those of other cell death inducers, indicating specific physiological characteristics of different cell death mechanisms, consequent to as well as independent of caspase activation.